Open Source Imaging Consortium (OSIC)

OSIC – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.

Our Mission

​OSIC brings together radiologists, clinicians, computational scientists, and industry competitors from around the world to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.

​The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients.  

Our first-of-its-kind, curated ILD database is rich with diverse, global data that is organized, accurate and accessible for research​

GOAL SURPASSED
15,000 anonymized scans with accompanying clinical data

COMMITTED ​TO DATE
20,789 anonymized scans with accompanying clinical data

Learn more

Driven by Leading Subject-matter Experts

The OSIC Core Science Leadership Team has partnered with a diverse team of experts to tackle the challenges of IPF, ILDs, and the technology needed to make progress.

Institutional Partners

​These organizations have made multi-year commitments of funding and/or pledged to contribute with imaging and clinical data or with other means to OSIC to ensure that it is positioned for success.